Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CC
stocks logo

CC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.34B
-1.56%
0.068
-38.5%
1.44B
+5.53%
0.132
+1.42%
1.64B
+1.73%
0.673
+15.96%
Estimates Revision
The market is revising Downward the revenue expectations for The Chemours Company (CC) for FY2025, with the revenue forecasts being adjusted by -1.53% over the past three months. During the same period, the stock price has changed by -19.92%.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.53%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-17.77%
In Past 3 Month
Stock Price
Go Down
down Image
-19.92%
In Past 3 Month
Wall Street analysts forecast CC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CC is 16.86 USD with a low forecast of 14.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast CC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CC is 16.86 USD with a low forecast of 14.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 12.540
sliders
Low
14.00
Averages
16.86
High
20.00
Current: 12.540
sliders
Low
14.00
Averages
16.86
High
20.00
JPMorgan
Neutral
downgrade
$15 -> $13
2025-12-03
New
Reason
JPMorgan
Price Target
$15 -> $13
2025-12-03
New
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Chemours to $13 from $15 and keeps a Neutral rating on the shares.
UBS
Joshua Spector
Buy
downgrade
$21 -> $18
2025-11-11
Reason
UBS
Joshua Spector
Price Target
$21 -> $18
2025-11-11
downgrade
Buy
Reason
UBS analyst Joshua Spector lowered the firm's price target on Chemours to $18 from $21 and keeps a Buy rating on the shares.
RBC Capital
Arun Viswanathan
Outperform
to
Outperform
downgrade
$19 -> $17
2025-11-10
Reason
RBC Capital
Arun Viswanathan
Price Target
$19 -> $17
2025-11-10
downgrade
Outperform
to
Outperform
Reason
RBC Capital analyst Arun Viswanathan lowered the firm's price target on Chemours to $17 from $19 and keeps an Outperform rating on the shares after its Q3 earnings miss. The stock saw a positive reaction to the quarter but remains down over 25% YTD as pricing pressure remains in TiO2, and operational upsets in Advanced Performance Materials are offsetting gains in Thermal & Specialized Solutions, the analyst tells investors in a research note.
Mizuho
John Roberts
Outperform
to
Outperform
downgrade
$18 -> $14
2025-11-07
Reason
Mizuho
John Roberts
Price Target
$18 -> $14
2025-11-07
downgrade
Outperform
to
Outperform
Reason
Mizuho analyst John Roberts lowered the firm's price target on Chemours to $14 from $18 and keeps an Outperform rating on the shares.
Mizuho
John Roberts
Outperform -> NULL
downgrade
$19 -> $18
2025-10-16
Reason
Mizuho
John Roberts
Price Target
$19 -> $18
2025-10-16
downgrade
Outperform -> NULL
Reason
Mizuho analyst John Roberts lowered the firm's price target on Chemours to $18 from $19 and keeps an Outperform rating on the shares. The firm says the TiO2 industry has bifurcated into essentially China versus western multi-national producers.
RBC Capital
Outperform
maintain
$15 -> $19
2025-10-14
Reason
RBC Capital
Price Target
$15 -> $19
2025-10-14
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Chemours to $19 from $15 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results for Chemicals companies. Recent conversations with the industry's Investor Relations teams have generally indicated that demand has remained somewhat tepid through Q3, the analyst tells investors in a research note. Building and Construction activity has been somewhat muted, and while rate cuts could help, a weak job market remains a headwind to new home starts and existing turnover, RBC added. Demand for consumer durables also has yet to see a material recovery, the firm states.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Chemours Co (CC.N) is 8.67, compared to its 5-year average forward P/E of 9.30. For a more detailed relative valuation and DCF analysis to assess Chemours Co 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
9.30
Current PE
8.67
Overvalued PE
12.83
Undervalued PE
5.78

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
6.75
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
7.79
Undervalued EV/EBITDA
5.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.66
Current PS
0.00
Overvalued PS
0.85
Undervalued PS
0.47
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CC News & Events

Events Timeline

(ET)
2025-11-06
16:35:25
Chemours anticipates a 10%-15% decline in Q4 revenue compared to the previous quarter.
select
2025-11-06
16:34:40
Chemours announces Q3 adjusted EPS of 20 cents, falling short of consensus estimate of 24 cents.
select
2025-09-03 (ET)
2025-09-03
06:46:01
Mary Cranston Appointed Chair of the Board at Chemours
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
06:13 AMNewsfilter
Chemours Appoints Michael Foley as President of Titanium Technologies Effective February 2026
  • Leadership Change: Chemours has appointed Michael Foley as President of Titanium Technologies, succeeding Damián Gumpel, effective February 2026, aiming to advance the company's value-driven strategy in the titanium sector.
  • Extensive Industry Experience: Foley brings a wealth of leadership experience from his previous role as President at Momentive Performance Materials, where he managed a $1 billion portfolio, which is expected to facilitate strategic transformation and operational excellence at Chemours.
  • Ongoing Support: During this transition, Chemours' current President and CEO, Denise Dignam, will provide leadership support to ensure continuity and smooth progress in the transformation of the Titanium Technologies business.
  • Strengthened Market Positioning: As one of the world's largest manufacturers of titanium dioxide, Foley's leadership is anticipated to drive further innovation and enhance partnerships with customers, thereby boosting Chemours' competitiveness in the coatings and plastics markets.
[object Object]
Preview
4.5
11-25Barron's
DuPont Poised for Growth: Why the Stock May Rise by 20%.
  • DuPont's Transition: After a decade of transactions, DuPont de Nemours is positioning itself to be recognized as a "compounder" stock, similar to Berkshire Hathaway and Danaher.
  • Investment Implications: This shift suggests potential for sustained growth and profitability, attracting investor interest in DuPont's future performance.
[object Object]
Preview
6.5
11-25Barron's
Deutsche Bank Recommends Buying DuPont Stock, Predicting It Could Evolve into a 'Compounder.'

  • DuPont's Growth Potential: After a decade of transactions, DuPont de Nemours is being recognized for its potential to become a significant growth compounder.

  • Analyst Insights: A Wall Street analyst has highlighted this potential, suggesting that DuPont could reach a new level of financial performance.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Chemours Co (CC) stock price today?

The current price of CC is 12.54 USD — it has decreased -3.24 % in the last trading day.

arrow icon

What is Chemours Co (CC)'s business?

The Chemours Company provides industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. The Company’s segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. The Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Opteon, Freon, Ti-Pure, Nafion, Teflon, Viton, and Krytox. The Company serves over 2,700 customers in approximately 110 countries.

arrow icon

What is the price predicton of CC Stock?

Wall Street analysts forecast CC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CC is 16.86 USD with a low forecast of 14.00 USD and a high forecast of 20.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Chemours Co (CC)'s revenue for the last quarter?

Chemours Co revenue for the last quarter amounts to 1.50B USD, decreased -0.86 % YoY.

arrow icon

What is Chemours Co (CC)'s earnings per share (EPS) for the last quarter?

Chemours Co. EPS for the last quarter amounts to 0.40 USD, decreased -290.48 % YoY.

arrow icon

What changes have occurred in the market's expectations for Chemours Co (CC)'s fundamentals?

The market is revising Downward the revenue expectations for The Chemours Company (CC) for FY2025, with the revenue forecasts being adjusted by -1.53% over the past three months. During the same period, the stock price has changed by -19.92%.
arrow icon

How many employees does Chemours Co (CC). have?

Chemours Co (CC) has 6000 emplpoyees as of December 05 2025.

arrow icon

What is Chemours Co (CC) market cap?

Today CC has the market capitalization of 1.88B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free